230950 Sigma-AldrichCiglitazone - CAS 74772-77-3 - Calbiochem
A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC₅₀ = 3 µM).
More>> A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC₅₀ = 3 µM). Less<<Sinónimos: (±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
74772-77-3 | C₁₈H₂₃NO₃S |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
230950-5MG |
|
Ampolla de plást. | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 74772-77-3 |
ATP Competitive | N |
Form | White to tan solid |
Hill Formula | C₁₈H₂₃NO₃S |
Chemical formula | C₁₈H₂₃NO₃S |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Selective PPARγ agonist |
Primary Target IC<sub>50</sub> | EC50 = 3 µM as PPARγ agonist |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | XJ5813700 |
Safety Information | |
---|---|
R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed. |
S Phrase | S: 36 Wear suitable protective clothing. |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
230950-5MG | 04055977218312 |
Documentation
Ciglitazone - CAS 74772-77-3 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Ciglitazone - CAS 74772-77-3 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
230950 |
Referencias bibliográficas
Visión general referencias |
---|
Jha, R.J. 1999. Clin. Exp. Hypertens. 21, 157. Xin, X., et al. 1999. J. Biol. Chem. 274, 9116. Lohrke, B., et al. 1998. J. Endocrinol. 159, 429. Willson, T.M., et al. 1996. J. Med. Chem. 39, 665. Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977. |